Introduction {#s1}
============

Tuberculosis (TB) is an infectious disease that remains a major public health problem in the world. Brazil is among 22 countries with major number of cases of TB in the world, with an incidence of 46/100,000 populations in 2012 and the distribution of TB cases varies greatly according to distinct geographic regions [@pone.0107106-WHO1]. In the state of Paraná (PR), south of Brazil, 2,350 new TB cases (incidence 22.4/100,000) were detected in 2011 [@pone.0107106-Agncia1]. However, these rates are higher in certain regions in the state of Paraná, such as in Paranaguá City, a port area, and on the triple border of Brazil/Paraguay/Argentina. The three municipalities concentrated near the border, which are Foz do Iguaçu in Brazil, Ciudad del Este in Paraguay and Puerto Iguazu in Argentina, have an incidence of 56.6/100,000, 42.5/100,000, and 23.4/100,000, respectively [@pone.0107106-Braga1]. These high rates are related to the living conditions of populations, lack of access to health services in some regions and high population mobility. Economic activities and tourism to see one of the New Seven Wonders of Nature, Iguazu Falls (Cataratas do Iguaçu), a waterfall on the Iguazu River on the border of the Brazilian state of Paraná and Misiones in Argentina, have provided strong population growth in Brazilian cities near to the border. In this setting, the constant and fast population mobility from one city to another can favors the spread of TB. In the two major municipalities at the Brazilian border, Foz do Igauçu and Cascavel, which have laboratory to perform culture for *Mycobacterium tuberculosis* and attend many others small surrounding cities for TB diagnosis had an incidence of TB 41.8/100,000 and 25.5/100,000 respectively.

Molecular typing methods have been used for a variety of epidemiological investigations and fast tracking geographic distribution of *M. tuberculosis* clusters [@pone.0107106-Foxman1]. Identical strains fingerprints are called clusters and are usually associated with recent transmission, while strains presenting unique fingerprint profile suggest remote transmission [@pone.0107106-Barnes1], [@pone.0107106-Masala1]. A PCR-based method, Mycobacterial Interspersed Repetitive Unit - Variable Number Tandem Repeat (MIRU-VNTR) typing allows the high throughput and discriminatory analysis of *M. tuberculosis* clinical isolates [@pone.0107106-Supply1], [@pone.0107106-Supply2]. The 15- and 24-MIRU-VNTR have been indicated for epidemiological and phylogenetical studies with *M. tuberculosis*. However, the 12-MIRU-VNTR added of Spoligotyping, another PCR based method, has been widely used in the molecular epidemiology of TB. Spoligotyping investigates the population structure of *M. tuberculosis*, focusing on the identification of genotypic lineages, spoligotype clades and their geographic distribution [@pone.0107106-Molhuizem1]. Spoligotyping has proven its usefulness for studying phylogeographical aspects of prevailing *M. tuberculosis* genotypic lineages and in combination with 12-MIRU-VNTR, it is highly discriminatory allowing the study of both the epidemiological and phylogeographical aspect of tubercle bacilli, including large-scale studies [@pone.0107106-Brudey1], [@pone.0107106-Santos1].

This study aimed to establish a first molecular insight of circulating genotypic lineages of *M. tuberculosis* in cities in the southwestern Paraná State, south of Brazil, which borders the countries of Paraguay and Argentina countries, based on Spoligotyping and 12-MIRU-VNTR typing.

Results {#s2}
=======

Patients, bacterial isolates and drug susceptibility test {#s2a}
---------------------------------------------------------

Of 96 *M. tuberculosis* identified, 64 (66.7%) were isolated from male patients, which account for a male/female ratio of about 2∶1 (M/F = 64/32). The age of patients ranged from 18 to 82 years old (36.75±13.38) and an age distribution of: 17--19 years, 4 (4.1%); 20--29 years, 25 (26.0%); 30--39 years, 35 (36.7%); 40--49 years, 18 (18.7%); 50--59 years, 5 (5,2%) and ≥60 years, 9 (9.3%). Drug susceptibility testing was performed on all 96 isolates and resistance was detected in 22 (22.92%); 20 (20.8%) were INH mono-resistant and 2 (2.1%) multidrug-resistant (MDR-TB) ([Table 1](#pone-0107106-t001){ref-type="table"}). All resistant *M. tuberculosis* isolates were from patients residing in the municipality of Cascavel, Parana, Brazil. Four of these isolates were obtained from prisoners.

10.1371/journal.pone.0107106.t001

###### Sex and age of patients and drug susceptibility, Spoligotyping and MIRU patterns of 96 *Mycobacterium tuberculosis* isolates from cities in southwestern Paraná, Brazil.

![](pone.0107106.t001){#pone-0107106-t001-1}

  isolates    Age   Sex   DST    Spoligotyping     MIRU                          
  ---------- ----- ----- ----- ----------------- --------- ------ -------------- -----
  1           30     M     H    777777607760731    LAM4      60    124326153324   246
  2           21     M     S    757757607760771   LAM9\*     /     124326143321    /
  3           30     M     H    777777607760731    LAM4      60    124326163324    /
  5           26     M     H    757777607760771    LAM9     822    124326143222    /
  6           26     M     H    777777607760771    LAM9      42    124326153326   816
  7           36     M     H    757777607760771    LAM9     822    124326153222   201
  8           38     M     H    757777607760771    LAM9     822    124326153322    /
  9           45     M     S    777777777760771     T1       53    324226153321    /
  11          25     M     H    777777777760731     T2       52    024326143324    /
  12          27     M     H    777777607760731    LAM4      60    324326143324    /
  13          30     M     H    777777607760731    LAM4      60    024326143324    /
  14          41     M     S    777777777760771     T1       53    324125153321    /
  15          31     M     S    777777777760731     T2       52    324326143324    /
  16          30     M     H    777777777760731     T2       52    324326143324    /
  17          25     M     S    777777777760771     T1       53    124326153324   246
  18          27     F     S    777777777760771     T1       53    224325153323   33
  19          61     F     S    777777777760771     T1       53    124326143326    /
  20          31     M     S    777777607760771    LAM9      42    224221143223    /
  21          60     M     H    777777607760771    LAM9      42    124326153224   140
  22          37     M     S    777777607760771    LAM9      42    024326143324    /
  23          49     F     S    377777607760771    LAM9     177    123226143321    /
  24          64     M     S    777777607760771    LAM9      42    124316153226    /
  25          39     M     S    377777607760771    LAM9     177    224226143321   738
  26          23     F     S    377777607760771    LAM9     177    224226153321   25
  27          24     M     H    777777607760771    LAM9      42    223326153323   236
  28          28     F     S    777777607760771    LAM9      42    124326143225    /
  29          32     M     S    777777607760771    LAM9      42    123226153321    /
  30          18     F     S    377777607760771    LAM9     177    123226153321    /
  31          50     M     S    377777677760771    T1\*      /     123216153321    /
  33          24     F     S    377777677760771    T1\*      /     123226153321    /
  34          43     M     H    777777777760771     T1       53    122222153321    /
  36          38     M     S    577777777760771     T1      334    223326153326   19
  37          18     M     S    763777777760771     T1      713    125326154323    /
  38          28     F     S    777777777760771     T1       53    123223173533    /
  39          72     F    MDR   777777607760731    LAM4      60    144326143324    /
  41          32     F     S    000377637760420     S\*      /     224316173228    /
  42          23     M     S    777777607760731    LAM4      60    224326143324   39
  43          22     M     H    777777607760731    LAM4      60    124326143324   519
  44          64     F     S    777777607760771    LAM9      42    124226153322    /
  45          48     F     S    757777607560771   LAM9\*     /     124326132223    /
  46          37     M     S    777777774020771     H1       47    224326132323    /
  47          41     M     S    777777777760771     T1       53    123323132321    /
  48          35     M     H    777777607760771    LAM4      60    223326132424    /
  49          34     M     S    777777607760731    LAM4      60    223326132324    /
  50          28     F     S    777777607560771   LAM6\*     /     124326132222    /
  51          42     F    MDR   777777607760731    LAM4      60    124326132324    /
  52          42     M     H    777777777760771     T1       53    224313132324    /
  53          41     F     H    777777607760731    LAM4      60    124326132324    /
  54          25     M     S    777777777760771     T1       53    224326132324    /
  55          30     F     S    777777607760731    LAM4      60    123326132324    /
  56          39     M     S    777777607560771    LAM6      64    121426132224    /
  57          61     F     S    577777607760771    LAM9     866    123326132321    /
  58          37     M     S    377777607760771    LAM9     177    224226132321    /
  59          28     M     S    777777607760771    LAM9      42    224236552326    /
  60          37     M     S    377777607760771    LAM9     177    224236152321    /
  61          21     M     S    000057607760000    X3\*      /     223236162228    /
  62          54     M     S    040054604020771   LAM8\*     /     225333550323    /
  63          22     M     S    377777607760771    LAM9     177    221236553321    /
  64          62     M     S    377777607760771    LAM9     177    224236553321    /
  65          30     F     S    777777607760731    LAM4      60    125336543324    /
  66          58     M     S    377777607760771    LAM9     177    224236553321    /
  67          58     F     S    777777607760731    LAM4      60    123336143324    /
  68          37     M     S    777774047560751   H37Rv\*    /     123336523322    /
  69          30     F     S    777764006020651   LAM8\*     /     223-36123522    /
  70          26     F     S    040000004020771    H2\*      /     123333523323    /
  71          27     F     S    040000004020771    H2\*      /     124313553323    /
  72          40     M     H    777777764760731    T1\*      /     223326553224    /
  73          66     M     S    777777647760771     T1      2298   124326543325    /
  76          54     M     S    776377777760771      S       34    234325153324    /
  77          35     F     H    777777607760731    LAM4      60    124326143324   519
  78          43     M     S    777777760720771     H\*      /     224325153321   161
  79          32     M     S    777777607760771    LAM9      42    225406143221    /
  82          30     M     S    777777607560771   LAM6\*     /     123206153122    /
  83          30     M     S    777777607560771   LAM6\*     /     124306153122    /
  85          29     F     S    377777607760771    LAM9     177    224306153128    /
  86          34     F     S    377777607760771    LAM9     177    224306153128    /
  87          30     M     H    777777607760731    LAM4      60    124306153324    /
  93          38     F     S    777777607760771    LAM9      42    224206153321    /
  94          49     F     S    577777607760771    LAM9     866    124306153326    /
  95          82     M     S    777777607760771    LAM9      42    223205173324    /
  96          38     M     S    777777777760771     T1       53    223405143322    /
  97          20     M     S    777777777760731     T2       52    124306143324    /
  98          22     M     S    677737677760661    T1\*      /     213205173321    /
  99          45     M     S    777777777760771     T1       53    224303143323    /
  100         25     M     S    776377777760771      S       34    233305143324    /
  104         40     M     S    677777777760771     T1      196    214205163321    /
  107         43     M     S    776377777760771      S       34    233325153224   218
  109         17     F     S    677777607760771    LAM1      20    224226143321   738
  110         61     M     S    776377777760771      S       34    233325153334    /
  111         25     F     S    777777600000331   LAM8\*     /     123326152224    /
  112         42     M     S    777777607720621   LAM9\*     /     224317153227    /
  115         31     F     S    777777774020771     H1       47    225313153323   42
  117         31     F     S    777777607760771    LAM9      42    224216143221    /
  118         31     M     S    777777607760731    LAM4      60    124026143321    /
  119         45     M     S    777777607760771    LAM9      42    123326143226    /
  120         22     F     S    776377777760771      S       34    233325153224   218

M: male; F: female; Drug susceptibility testing, DST; H, isoniazid resistant; MDR, isoniazid and rifampicin resistant; S, susceptible to isoniazid, rifampicin and pyrazinamide; SIT, Shared International Types; MIT, MIRU international types; -, no amplification; /, not described in SITVITWEB database; \* family assignment by SPOTCLUST.

Spoligotyping and MIRU-VNTR typing {#s2b}
----------------------------------

The distribution of 96 *M. tuberculosis* isolates analyzed by spoligotyping revealed 30 distinct patterns (n = 77, 80.2% isolates) and 15 (n = 19, 19.8% isolates) that have not been described in SITVITWEB database yet. According to SITVITWEB database, 71/77 (92.2%) isolates were clustered into nine Shared International Types (SIT), comprising from 2 to 17 isolates each cluster and the remaining 6 (7.8%) isolates showed unique SIT. The main SITs found in the present study were SIT60 (n = 17, 17.7%), SIT42 (n = 15, 15.6%), SIT53 (n = 12, 12.5%), and SIT177 (n = 11, 11.5%). The 77 (80.2%) isolates, identified in the SITVITWEB database, had been classified into clades and sublineages, which ranked in four clades, Latin American and Mediterranean (LAM) clade and sublineages, ill-defined T clade and sublineages, S and Haarlem (H) clades with 50 (52.1%), 20 (20.8%), 5 (5.2%) and 2 (2.1%) isolates, respectively ([File S1](#pone.0107106.s001){ref-type="supplementary-material"}).

Out of 19 (19.8%) isolates none identified in SITVITWEB database, 11 (11.5%) had unique SIT and the remaining 8 (8.3%) were included in 4 clusters, comprising 2 isolates for each one ([Table 1](#pone-0107106-t001){ref-type="table"}). The clades assignment for these isolates, by SPOTCLUST, revealed that 9 (47.4%) belonged to the LAM, 4 (21.1%) to T and 3 (15.8%) to H. There were three other isolates pertaining to X, S and H~37~Rv ([Table 1](#pone-0107106-t001){ref-type="table"}).

12 loci-MIRU-VNTR typing conducted in the 96 clinical isolates showed a total of 85 distinct MIRU patterns ([File S1](#pone.0107106.s001){ref-type="supplementary-material"}). Seventy-six (79.2%) isolates had unique patterns and the remaining 20 (20.8%) were included in 9 clusters comprising 2 to 3 isolates for each one ([Table 1](#pone-0107106-t001){ref-type="table"}). Out of 96 isolates, 18 were identified in the SITIVITWEB database pertaining to MIRU international types (MITs) 19, 25, 33, 39, 42, 140, 161, 201, 218, 236, 246, 519, 738 and 816 ([Table 1](#pone-0107106-t001){ref-type="table"}).

Allele polymorphism analysis of 12 loci-MIRU-VNTR by Hunter*-*Gaston Discrimination Index (HGDI) [@pone.0107106-Hunter1], revealed that MIRU locus 40 was the most discriminatory with 8 alleles, followed by MIRU locus 26 with 6 alleles. In the MIRU locus 40 the presence of single copy and 4 alleles were the most frequent. MIRU loci 2, 10, 16, 20, 23, 27 and 31 were moderately discriminant. MIRU loci 4, 24 and 39 were the poorly discriminant ([Table 2](#pone-0107106-t002){ref-type="table"}). The amplification of MIRU *locus* 16 of isolate 69 was not possible.

10.1371/journal.pone.0107106.t002

###### Allele polymorphism by 12 loci-MIRU-VNTR of 96 *Mycobacterium tuberculosis* from cities in southwestern Paraná, Brazil.

![](pone.0107106.t002){#pone-0107106-t002-2}

  MIRU no.    Allele no.   HGI [a](#nt102){ref-type="table-fn"}   Conclusion                                      
  ---------- ------------ -------------------------------------- ------------ ---- ---- ---- ---- --- --- ------- -------------------------
  MIRU 2          3                         46                        42       5                           0.581   Moderately discriminant
  MIRU 4                                    2                         89       5                           0.139     Poorly discriminant
  MIRU 10                                   2                         1        29   59   5                 0.533   Moderately discriminant
  MIRU 16         1                         1                         26       65   3                      0.499   Moderately discriminant
  MIRU 20         15                        8                         61       12                          0.555   Moderately discriminant
  MIRU 23                                   1                         1        8         12   73   1       0.404   Moderately discriminant
  MIRU 24                                   85                                           11                0.205     Poorly discriminant
  MIRU 26                                                             3        14   29   43   3    4       0.690     Highly discriminant
  MIRU 27                                   1                         18       76   1                      0.342   Moderately discriminant
  MIRU 31                                   4                         19       70   1    2                 0.431   Moderately discriminant
  MIRU 39                                                             94       2                           0.021     Poorly discriminant
  MIRU 40                                   26                        10       12   34   2    7    1   4   0.775     Highly discriminant

HGI: Hunter-Gaston index.

The allelic diversity of the loci was classified as highly discriminant (HGI \>0.6), moderately discriminant (0.3≥ HGI ≤0.6) and poorly discriminant (HGI \<0.3).

All 96 *M. tuberculosis* isolates analyzed by spoligotyping and 12-MIRU-VNTR typing combined could be genotypically differentiated in 90 patterns. In this analysis, 84 (87.50%) isolates showed distinct genotypes and 12 (12.50%) were included into six clusters (2 isolates each with 100% similarity) ([Table 3](#pone-0107106-t003){ref-type="table"}).

10.1371/journal.pone.0107106.t003

###### Clusters by Spoligotyping/MIRU combination and epidemiological data of 12 *Mycobacterium tuberculosis* isolates from patients in cities in southwestern Paraná, Brazil.

![](pone.0107106.t003){#pone-0107106-t003-3}

  Isolates     spoligotyping     MIRU-VNTR     Date of culture/microscopy of Baciloscopy   DST             Epidemiologic relationships
  ---------- ----------------- -------------- ------------------------------------------- ----- -------------------------------------------------
  15          777777777760731   324326143324                  11/25/2009                    S               No epimiological relation
  16          777777777760731   324326143324                  07/30/2010                    H               No epimiological relation
  43          777777607760731   124326143324                  06/28/2010                    H    Live in the same neighborhood and nearby street
  77          777777607760731   124326143324                  11/28/2010                    H   
  51          777777607760731   124326132324                  07/25/2010                   MDR              No epimiological relation
  53          777777607760731   124326132324                  07/30/2010                    S               No epimiological relation
  64          377777607760771   224236553321                  09/20/2010                    S              Live in neighboring cities
  66          377777607760771   224236553321                  10/20/2010                    S   
  85          377777607760771   224306153128                  29/12/2010                    S               No epimiological relation
  86          377777607760771   224306153128                  13/01/2011                    S               No epimiological relation
  107         776377777760771   214205163321                  17/05/2010                    S               No epimiological relation
  120         776377777760771   233325153224                  10/05/2011                    S               No epimiological relation

DST, Drug susceptibility testing; H, isoniazid resistant; MDR, isoniazid and rifampicin resistant; S, susceptible to isoniazid, rifampicin and pyrazinamide.

Discussion {#s3}
==========

This is the first study conducted to establish the circulating genotypic lineages of *M. tuberculosis* isolated from TB patients in southwestern Paraná, Brazil that borders the countries of Paraguay and Argentina. Economic activities and tourism in the triple border have provided strong population growth in some cities from the Brazil border, mainly in Cascavel and Foz do Iguaçu. Constant population mobility and the rapid migration for commercial purpose, from one city to another one, at the triple border, may favor the spread of TB in this setting.

The age and sex distribution of patients in our study reflects the predominance of TB among adult male people (81.4% of all patients) as observed in all other regions in the word [@pone.0107106-WHO1]. The 2∶1 male to female sex-ratio may be explained by the local socio-cultural barriers. In this setting, women stay mainly at home and men are engaged in external activity, which leads the latter to a higher exposition to the bacillus. In the present study, the prevalent isolates came from Cascavel, Foz de Iguaçu and other surrounding small cities.

The LAM, T and H were the largest clades observed in the present study, the three genotypic clades most frequent in Africa, Central America, Europe and South America [@pone.0107106-Brudey1]. The present results are similar to a previous one, carried out in our laboratory, by Noguti et al. [@pone.0107106-Noguti1], which had greater variability in SITs, but LAM, H and T were the largest clades in the northwestern Paraná. In Araraquara, São Paulo State, which borders northern Paraná, Mendes et al. [@pone.0107106-Mendes1] identified 73% of spoligopatterns in SpolDB4, and LAM, T and H clades were the most prevalent too. More recently, Santos et al. [@pone.0107106-Santos1], in a comparative study between 1998--2001 and 2002--2006, observed replacement of ill-defined T family for LAM in Araraquara, São Paulo. Furthermore, there are a number of lineages found in Northern Paraná and São Paulo States studies, including Beijing, which was not detected in the present study.

The most prevalent SITs in southwestern Paraná were 60 (prototype of LAM4), 42 (prototype of LAM9), 53 (prototype of T1) and 177 (prototype of LAM9). These four most prevalent SITs observed in our study were found in Argentina too, as reported in SITVITWEB and SpolDB4, but no reference to Paraguay was made [@pone.0107106-Brudey1].

The SITs 334 and 713 (both susceptible and prototype of T1), characterized by one isolate for each one, have not been described in Paraguay and Argentina yet. The first one has been described in Brazil only once, but the second hasn\'t been yet (<http://www.pasteur-guadeloup.fr:8081/SITVITDemo/>). The other spoligopatterns, which were described in SITVITWEB database, were already identified in Brazil and some of them in Argentina and Paraguay. The SITs 52 (prototype of T2), 60 (prototype of LAM4), 196 (prototype of T1), 822 (prototype of LAM9) and 866 (prototype of LAM9) were described for the first time in Paraná, Brazil (<http://www.pasteur-guadeloup.fr:8081/SITVITDemo/>). Of interest, INH mono-resistant was predominant in isolates genotyped as SIT60 (LAM4, 9 isolates), which is frequent in the Americas and some countries in Europe (<http://www.pasteur-guadeloup.fr:8081/SITVITDemo/>). The two MDR were genotyped as SIT 60 (LAM4) but had different MIRU patterns.

The spoligoforest tree indicates that there are conserved genotypes as the SIT53 (prototype of T1), which demonstrated the ability to generate 7 other genotypes, by the loss of 1 to 6 spacers, which predominate T clade. We could observe with SIT42 (prototype of LAM9) that the loss of only one spacer, in a different section of DR region, yielded 6 different SITs (20, 60, 64, 177, 822, 866) belonging to the LAM clade ([figure 1](#pone-0107106-g001){ref-type="fig"}).

![Spoligoforest tree of 96 *M. tuberculosis* clinical isolates from cities in the southwestern Paraná, Brazil, showing all spoligotyping clades represent changes (loss of spacers) by lane.\
Edges between nodes reflect evolutionary relationships between spoligotypes with arrowheads pointing to descendants. The area of each node is proportional to the number of isolates.](pone.0107106.g001){#pone-0107106-g001}

We observed a total of 9 single locus variation (SLV) events within the 12-locus subset. The best discriminatory power was obtained considering that a unique SLV in any one of the loci analyzed, remains strongly predictive of the absence of a link between the isolates. According to Hunter and Gaston [@pone.0107106-Hunter1] the most allelic diversity observed in the *M. tuberculosis* isolates studied was in MIRU loci 40 and 26 and moderated polymorphism were found in MIRU loci 2, 10, 16, 20, 23, 27 and 31. These allelic diversities also differs from the obtained in northwestern Paraná by Noguti et al. [@pone.0107106-Noguti1] that observed most allelic diversity in MIRU loci 40, 23, 10 and 16 and moderate polymorphism in MIRU loci 26, 20 and 31. Sharma et al. [@pone.0107106-Sharma1] working with only 6 loci-MIRU (MIRU 4, 10, 16, 26, 39 and 40) observed the most discriminatory loci, in order of diversity, 26, 10, 16 and 40 in isolates from Kanpur, India. Kovalev et al. [@pone.0107106-Kovalev1] observed most allelic diversity in MIRU loci 26, 31 and 10 in *M. tuberculosis* isolated in Ural region, Russian Federation. On the other hand these authors refer to MIRU locus 23 as having the lowest discriminatory power, differing from our results, which was MIRU 39.

Despite of high discriminatory power of MIRU typing observed in our study, there were isolates clustered by this method. In these cases, some clustered isolates (25, 109, 29, 30, 1, 17, 11, 13 and 22) were discriminated by spoligotyping, demonstrating the need of using these two techniques combined to provide a higher discriminatory power. In this sense, Spoligotyping combined to 12 loci-MIRU-VNTR allowed 90 different molecular patterns for all 96 *M. tuberculosis* isolates analyzed. In these patterns there were 12 isolates that weren\'t possible to be differentiated as unique and were included in six patterns with two isolates each one. Four these clustered isolates are of particular concern to be discussed. The isolates 43 and 77, which were INH mono-resistant, were obtained from patients, who lived in the same neighborhood and nearby streets and were referred to the central laboratory in Cascavel for TB laboratorial diagnosis in the same year. Two other isolates (64 and 66) with the same spoligopattern and MIRU, were obtained from patients that lived in neighboring cities (Cascavel and Campo Bonito) and were referred to the central laboratory in Cascavel for TB laboratorial diagnosis. Thus, to overcome the observed limitation, additional study should be considered by using optimized 15- and 24- loci-MIRU typing to differentiate the isolates and provide additional data about any isolates relationship.

In conclusion, our study offers the first baseline about the genetic diversity of *M. tuberculosis* isolated from patients with TB in cities in southwestern Paraná State, Brazil, which borders two other countries, Paraguay and Argentina. This kind of study is important for tracing relationships among the strains and recognition of the mainly clades responsible for spreading the disease. One limitation of the present study is the small number of isolates from some cities in the samples. However this issue will be addressed by additional and better designed studies in this setting, with a higher timescale and number of isolates conducted in the future to understand the chain of TB transmission in this region.

Materials and Methods {#s4}
=====================

Patients, bacterial isolates and drug susceptibility test {#s4a}
---------------------------------------------------------

The study was approved by the Ethics Committee of the State University of Maringa, Parana (protocol No. 018/2011, CAAE No. 0375.0.093.000-10). The information about sex, age, clinical features and address of patients was collected by reviewing the national TB notification database. As the study was conducted with *M. tuberculosis* isolated from sputa that were disposed of, in accordance with internal biosecurity rules, after test results release to the patient, and no additional patients\' sputa samples and information, which could to identify them were requested (identification was carried out by a number given to each patient), the document participant consents achievement were exempted by the ethics committee. The study included 120 patients (66.7% male patients, age range from 17 to 82 years old) from 10 cities in southwestern Paraná, Brazil, which borders Paraguay and Argentina countries ([Figure 2](#pone-0107106-g002){ref-type="fig"}), with confirmed pulmonary TB by microscopy (Ziehl-Neelsen - ZN) and culture (Ogawa medium -- OK). All patients were attended at two central laboratories in Cascavel and Foz do Iguaçu cities, southwestern Paraná, from July 2009 to July 2011. Of these, 96 isolates (80%) were identified as *M. tuberculosis* by biochemical methods [@pone.0107106-Kent1] and drug susceptibility tests (DSTs) were carried out for Isoniazid (INH), Rifampicin (RMP) and Pyrazinamide (PZA) by Löwenstein-Jensen (L-J) Proportion Method [@pone.0107106-Brasil1].

![The triple border Brazil/Paraguay/Argentina, with the location of the cities of Foz do Iguacu and Cascavel (Brazil), Ciudad del Este (Paraguay) and Puerto Iguazú (Argentina).](pone.0107106.g002){#pone-0107106-g002}

Spoligotyping and MIRU-VNTR typing {#s4b}
----------------------------------

*M. tuberculosis* DNA of 96 *M. tuberculosis* isolates were extracted from cultured cells as described by Cardoso et al. [@pone.0107106-Cardoso1] and subjected to genotyping by spoligotyping to detect presence or absence of 43 spacers by using the standard method [@pone.0107106-Molhuizem1], [@pone.0107106-Dale1] and by the original 12-MIRU-VNTR loci (2, 4, 10, 16, 20, 23, 24, 26, 27, 31, 39 and 40) as described by Supply et al. [@pone.0107106-Supply1], [@pone.0107106-Supply3]. MIRU allele scoring was determined according to Mazars et al. [@pone.0107106-Mazars1] and Supply et al. [@pone.0107106-Supply2]. The results from each of the 12 loci were combined to create 12-digit allelic profiles. The power of discriminating 12 loci was determined by Hunter*-*Gaston Discrimination Index (HGDI) [@pone.0107106-Hunter1].

Database analysis {#s4c}
-----------------

The spoligo and 12-loci-MIRU patterns were compared to international database SITIVITWEB (Institute Pasteur de la Guadalupe) [@pone.0107106-Demay1], which is an updated version of the published SpolDB4.0 database [@pone.0107106-Brudey1] and available at [www.pasteur-guadeloupe.fr:8081/SITVITDemo/](http://www.pasteur-guadeloupe.fr:8081/SITVITDemo/). The spoligopatterns not identified in SITVITWEB database were assigned in families by SPOTCLUST at <http://cgi2.cs.rpi.edu/~bennek/SPOTCLUST.html>. For additional analysis a phylogenetic tree (spoligoforest) was constructed with data from spoligotyping using SpolTools at <http://www.emi.unsw.edu.au/spolTools/>.

BioNumerics software (version 4.45; Applied Maths, Sint-Martens-Latem, Belgium) was used for analysis of Spoligotyping and MIRU-VNTR patterns. Dendrogram was constructed for Spoligotyping and MIRU-VNTR combined. The genetic distance was built employing the UPGMA algorithm (Unweighted Pair Group Method with Arithmetic Mean).

Supporting Information {#s5}
======================
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**Sex and age of patients and drug susceptibility profile, Spoligotyping and MIRU typing of 96** ***Mycobacterium tuberculosis*** **clinical isolates from cities in southwestern Paraná, Brazilian borders with Argentina and Paraguay.**
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###### 

Click here for additional data file.
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